Heart News and Research

RSS

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study

Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug (pioglitazone), concludes a study published on bmj.com today.

20 Aug 2009

Saskatchewan government makes insulin detemir more accessible to residents

The Canadian Diabetes Association applauds the Government of Saskatchewan for increasing access to insulin detemir for residents of Saskatchewan living with diabetes. Insulin detemir, also known as Levemir, has been added to the Saskatchewan Drug Formulary, under Exception Drug Status (EDS) effective July 1, 2009. As well, the updated formulary now includes NovoRapid-NOO, Apidra-AVT and Humalog-LIL within its Revised Exception Drug Status Criteria.

20 Aug 2009

Consumer-friendly "finger stick" blood test to detect cardiovascular disease is broadly available now

A new blood test, measuring the level of omega-3 fatty acids in red blood cells, is now broadly available for the first time to the public everywhere as a consumer-friendly, at-home "finger stick" test. While scientists have long known of the benefits of fish and fish oil for overall heart health, over the past decade research has proven that the omega-3 fatty acids found in fish dramatically reduce one's risk for cardiovascular disease. Further, recent research indicates that omega-3 levels may be among the best predictors of future coronary heart disease - providing much stronger correlations to the risk of sudden cardiac death than traditional indicators, including HDL and LDL cholesterol.

20 Aug 2009

Nutrisystem's 28-Day program maintains an affordable per-meal cost

Nutrisystem, Inc., a leading provider of weight management products and services that are delivered directly to the customers' doors, announced today that its popular 28-Day Nutrisystem Select program now includes an additional week of delicious fresh-frozen entrees - all for the same low monthly cost.

20 Aug 2009

Reliv International's chief scientific officer suggests tips to improvise lifestyle as age increases

According to the Centers for Disease Control and Prevention, the United States is on the "brink of a longevity revolution." In fact, by 2030, one in every five Americans will be over the age of 65. So, what can adults do now to ensure that they continue to enjoy a great lifestyle in their later years? In honor of Healthy Aging Month this September, Dr. Carl Hastings, chief scientific officer of Reliv International, offers some advice.

20 Aug 2009

Diet pills, alcohol, caffeine, nicotine, amphetamines and cocaine abused by patients with eating disorders

Between 11 and 13 million people in the U.S. have eating disorders and at least one million will die from their disorder. It is not unusual for women and girls struggling with eating disorders to either abuse or become dependent on over-the-counter substances.

20 Aug 2009

National Science Foundation funds CMU for developing revolutionary computational tools

A multidisciplinary team led by Carnegie Mellon University computer scientist Edmund M. Clarke has received a five-year, $10 million grant from the National Science Foundation's Expeditions in Computing program to create revolutionary computational tools that will advance science on a broad array of fronts, from discovering new cancer treatments to designing safer aircraft.

20 Aug 2009

3M introduces Littmann electronic stethoscope with Bluetooth

Taking the stethoscope into the 21st century, 3M today announced the introduction of the 3M™ Littmann® Electronic Stethoscope Model 3200, a next-generation auscultation device featuring Bluetooth technology that wirelessly transfers heart, lung and other body sounds to software for further analysis.

19 Aug 2009

Newly discovered anti-aging gene linked to high blood pressure

Researchers at the University of Oklahoma Health Sciences Center have shown the first link between a newly discovered anti-aging gene and high blood pressure. The results, which appear this month in the journal Hypertension, offer new clues on how we age and how we might live longer.

19 Aug 2009

Health Research International publishes reports on opportunities presented by transcatheter and minimally invasive surgical valve technologies

Transcatheter heart valve technologies are positioned to become the next disruptive influence in cardiovascular medicine and drive a multi-billion dollar market. However, questions remain about the timing of adoption of these new technologies, the numbers and types of patients ultimately benefitting from them, the impact of reimbursement, and where transcatheter technologies pose the greatest threat to the current surgical caseload, especially in light of developments in minimally invasive heart valve surgery technologies.

19 Aug 2009

Researchers find connection between eye disease and arginase

Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.

19 Aug 2009

Computed tomography angiography can identify abnormalities and injury beyond the pulmonary arteries

Children with clinically suspected pulmonary embolism (PE) are increasingly being evaluated with CT angiography (CTA). Even though many children ultimately test negative for PE, study results suggest that CTA is still valuable for this indication because it has the ability to accurately detect a variety of alternative diagnoses.

19 Aug 2009

Medicare picks twelve New Jersey hospitals to test incentive system

Twelve New Jersey hospitals and their participating physicians have received approval from the federal government to test an innovative new incentive method that aims to reduce healthcare costs while improving quality of care.

19 Aug 2009

Bioheart's executive management team strengthened by the inclusion of board members

Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.

19 Aug 2009

New understanding on meningitis cause

A specific protein on the surface of a common bacterial pathogen allows the bacteria to leave the bloodstream and enter the brain, initiating the deadly infection known as meningitis. The new finding, which may guide development of improved vaccines to protect those most vulnerable, including young infants and the elderly, is now available online in the Journal of Experimental Medicine.

19 Aug 2009

Fatigue during radiotherapy for breast or prostate cancer may be caused by inflammation

Patients who experience fatigue during radiotherapy for breast or prostate cancer may be reacting to activation of the proinflammatory cytokine network, a known inflammatory pathway, according to a report in Clinical Cancer Research, a journal of the American Association for Cancer Research.

19 Aug 2009

Gfk Healthcare launches Brand BEAT to provide a holistic evaluation of brand equity

GfK Healthcare, the largest provider of fully integrated custom health care marketing research in the United States, announced today the launch of Brand BEAT™ (Brand Equity Assessment & Tracking), a complete package of health care-specific brand positioning diagnostic tools for measuring the cognitive and emotional strengths of a brand.

19 Aug 2009

CryoLife's SynerGraft technology effective in removing donor cells and cellular remnants from the tissue

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced the first three implantations of the CryoPatch((R)) SG pulmonary human cardiac patch since FDA clearance.

19 Aug 2009

Study shows lower short-term mortality rates in patients hospitalized for AMI

From 1995 to 2006, hospital 30-day death rates decreased significantly for Medicare patients hospitalized for a heart attack, as did the variation in the rate between hospitals, according to a study in the August 19 issue of JAMA.

19 Aug 2009

Beveragette Ventures launches all-natural beverage to minimize common PMS and menopause symptoms

Seattle-based, women-owned, Beveragette Ventures LLC, developers of the innovative, wellness beverage line, GEM, announced today the launch of Keep it Cool(TM), an all-natural, low-calorie, peach-pineapple flavored beverage, with clinically proven ingredients to minimize the many symptoms of menopause; hot flashes, night sweats, mood swings, irritability and sleeplessness.

19 Aug 2009

Heart News and Research

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study

Saskatchewan government makes insulin detemir more accessible to residents

Consumer-friendly "finger stick" blood test to detect cardiovascular disease is broadly available now

Nutrisystem's 28-Day program maintains an affordable per-meal cost

Reliv International's chief scientific officer suggests tips to improvise lifestyle as age increases

Diet pills, alcohol, caffeine, nicotine, amphetamines and cocaine abused by patients with eating disorders

National Science Foundation funds CMU for developing revolutionary computational tools

3M introduces Littmann electronic stethoscope with Bluetooth

Newly discovered anti-aging gene linked to high blood pressure

Health Research International publishes reports on opportunities presented by transcatheter and minimally invasive surgical valve technologies

Researchers find connection between eye disease and arginase

Computed tomography angiography can identify abnormalities and injury beyond the pulmonary arteries

Medicare picks twelve New Jersey hospitals to test incentive system

Bioheart's executive management team strengthened by the inclusion of board members

New understanding on meningitis cause

Fatigue during radiotherapy for breast or prostate cancer may be caused by inflammation

Gfk Healthcare launches Brand BEAT to provide a holistic evaluation of brand equity

CryoLife's SynerGraft technology effective in removing donor cells and cellular remnants from the tissue

Study shows lower short-term mortality rates in patients hospitalized for AMI

Beveragette Ventures launches all-natural beverage to minimize common PMS and menopause symptoms

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News